Screener
Bio-Techne TECH Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | March 31, 2026 / (unaudited) | June 30, 2025 |
|---|---|---|
| Other current liabilities | 2,092 | 1,645 |
| Total current liabilities | 153,278 | 175,849 |
| Deferred income taxes | 14,210 | 6,169 |
| Long-term debt obligations | 200,000 | 346,000 |
| Operating lease liabilities | 76,141 | 83,960 |
| Other long-term liabilities | 21,668 | 27,082 |
| Shareholders’ equity: | ||
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding | — | — |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's long-term debt?
- Bio-Techne (TECH) reported long-term debt of $200M in Q1 2026.
- How has Bio-Techne's long-term debt changed year-over-year?
- Bio-Techne's long-term debt decreased by 39.4% year-over-year, from $330M to $200M.
- What is the long-term trend for Bio-Techne's long-term debt?
- Over 4 years (2021 to 2025), Bio-Techne's long-term debt has grown at a 1.3% compound annual growth rate (CAGR), from $328.83M to $346M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Bio-Techne's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude